F. Bosch

F. X. Bosch, N. Muñoz, C. Meijer, 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Eradication of cervical cancer in Latin America.

F. X. Bosch, F. Bosch, 2016, Salud publica de Mexico.

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

S. Franceschi, F. X. Bosch, N. Muñoz, 2003, Journal of the National Cancer Institute.

Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.

N. Muñoz, H. Kitchener, S. Sanjosé, 2014, European journal of cancer.

Social differences in sexual behaviour and cervical cancer.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1997, IARC scientific publications.

Epidemiology of liver cancer in Europe.

F. X. Bosch, J. Ribes, F. Bosch, 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

C. Wheeler, F. X. Bosch, N. Muñoz, 2009, Human vaccines.

Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.

Kathleen R. Cho, J. Vogelstein, F. X. Bosch, 1997, Cancer research.

Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells

Harald, F. X. Bosch, N. Fusenig, 1990, Journal of virology.

Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort

I. Gram, F. Clavel-Chapelon, A. Fournier, 2016, PloS one.

Organotypic co-cultures allow for immortalized human gingival keratinocytes to reconstitute a gingival epithelial phenotype in vitro.

F. X. Bosch, M. Roesch-Ely, G. Komposch, 2006, Differentiation; research in biological diversity.

Environmental co-factors in HPV carcinogenesis.

F. X. Bosch, N. Muñoz, X. Castellsagué, 2002, Virus research.

CHAPTER 2 The epidemiology of human papillomavirus infection and its association with cervical cancer

F. X. Bosch, Y. Qiao, X. Castellsagué, 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult men.

R. Peeling, S. Franceschi, F. X. Bosch, 2005, American journal of epidemiology.

Cervical cancer control, priorities and new directions

J. T. Cox, P. Coursaget, F. X. Bosch, 2004, International journal of cancer.

Prevalence and determinants of human papillomavirus genital infection in men

M. Plummer, S. Franceschi, F. X. Bosch, 2002, British Journal of Cancer.

Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia.

F. X. Bosch, N. Muñoz, X. Castellsagué, 1997, The Journal of infectious diseases.

Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease.

F. X. Bosch, N. Muñoz, S. Sanjosé, 1996, Journal of the National Cancer Institute.

Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain.

F. X. Bosch, N. Muñoz, S. Sanjosé, 1996, Journal of the National Cancer Institute.

Human papillomavirus and invasive cervical cancer in Brazil.

F. X. Bosch, N. Muñoz, C. Meijer, 1994, British Journal of Cancer.

Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Joakim Dillner, Daron G Ferris, Susanne K Kjaer, 2010, Journal of the National Cancer Institute.

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

C. Wheeler, F. X. Bosch, N. Muñoz, 2009, Cancer Prevention Research.

Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.

Milton C Weinstein, Sue J Goldie, Thomas C Wright, 2004, Journal of the National Cancer Institute.

Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners

S. Franceschi, N. Muñoz, S. Sanjosé, 2002 .

The male role in cervical cancer.

F. X. Bosch, N. Muñoz, X. Castellsagué, 2003, Salud publica de Mexico.

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

Xavier Castellsagué, Rosanna W Peeling, Silvia de Sanjosé, 2006, Journal of the National Cancer Institute.

Human papillomavirus and other risk factors for cervical cancer.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

73 – Cervical Cancer

F. X. Bosch, N. Muñoz, F. Bosch, 2000 .

Correspondence Re: M. Schiffman and A. Schatzkin, test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res. (suppl.), 54: 1944s-1947s, 1994.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1994, Cancer research.

Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.

F. X. Bosch, F. Rösl, G. Halec, 2009, Cancer research.

The role of vegetable and fruit consumption and other habits on survival following the diagnosis of oral cancer: a prospective study in Spain.

F. X. Bosch, X. Castellsagué, M. Quintana, 2009, International journal of oral and maxillofacial surgery.

IARC Monographs on the evaluation of carcinogenic risks to humans: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene

Leslie T. Stayner, Len Levy, Takumi Yoshizawa, 2002 .

Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries

S. Franceschi, F. X. Bosch, N. Muñoz, 2009, British Journal of Cancer.

Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: The CLEOPATRE study

Laurence Serradell, Xavier Castellsagué, F. X. Bosch, 2012, Journal of medical virology.

Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.

F. X. Bosch, P. van Damme, M. Kane, 2012, Vaccine.

Combined analysis of matched and unmatched case-control studies: comparison of risk estimates from different studies.

V. Moreno, F. X. Bosch, N. Muñoz, 1996, American journal of epidemiology.

Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

Jack Cuzick, Jorma Paavonen, Cosette M. Wheeler, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Cost-effectiveness of human papillomavirus vaccination and screening in Spain.

F. X. Bosch, S. de Sanjosé, S. Goldie, 2010, European journal of cancer.

Transcript and proteome analysis reveals reduced expression of calgranulins in head and neck squamous cell carcinoma.

F. X. Bosch, A. Dietz, A. Ruess, 2005, European journal of cell biology.

Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)

M. Poljak, J. Cuzick, F. X. Bosch, 2020, British Journal of Cancer.

Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective

C. Wheeler, J. Peto, F. X. Bosch, 1997, Journal of virology.

The causal link between HPV and cervical cancer and its implications for prevention of cervical cancer.

F. X. Bosch, N. Muñoz, F. Bosch, 1996, Bulletin of the Pan American Health Organization.

Re: Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer.

J. Cuzick, S. Franceschi, D. Lowy, 2001, Journal of the National Cancer Institute.

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

C. Wheeler, F. X. Bosch, N. Muñoz, 2010, BMJ : British Medical Journal.

HPV vaccines and cervical cancer.

F. X. Bosch, F. Bosch, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Reducing Liver Cancer--Global Control of Aflatoxin

F. X. Bosch, T. Troxell, S. Henry, 1999, Science.

Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain.

D. Lowy, F. X. Bosch, N. Muñoz, 1995, The Journal of infectious diseases.

Correlation between the presence of anti HPV33 VLP antibodies and HPV DNA in cervical neoplasia patients

F. X. Bosch, K. Shah, M. Sapp, 1997, Archives of Virology.

Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer

F. X. Bosch, N. Muñoz, X. Castellsagué, 1992, Journal of clinical microbiology.

The epidemiology of primary liver cancer: global epidemiology

F. X. Bosch, J. Ribes, F. Bosch, 2002 .

Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide

S. Franceschi, F. X. Bosch, N. Muñoz, 2006, International journal of cancer.

Risk of first cervical HPV infection and precancerous lesions after onset of sexual activity Castellsague

C. Wheeler, F. X. Bosch, M. Lehtinen, 2022 .

Epilogue: Looking forward to cervical cancer elimination

F. X. Bosch, D. Jenkins, F. Bosch, 2020 .

Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines

F. X. Bosch, H. zur Hausen, A. Schneider, 1991, Journal of virology.

Infections and the Etiology of Human Cancer: Epidemiological Evidence and Opportunities for Prevention

F. X. Bosch, S. Sanjosé, J. Ribes, 2003 .

Oral and oropharyngeal cancer in Spain: influence of dietary patterns

S. Franceschi, F. X. Bosch, N. Muñoz, 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Smoking as a major risk factor for cervical cancer and pre‐cancer: Results from the EPIC cohort

I. Gram, F. Clavel-Chapelon, E. Riboli, 2014, International journal of cancer.

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India

F. X. Bosch, G. Albero, S. de Sanjosé, 2008, British Journal of Cancer.

Risk factors for hepatocellular carcinoma in catalonia, spain

F. X. Bosch, J. Bruix, J. Estève, 1990, International journal of cancer.

Effect of riboflavin, retinol, and zinc on micronuclei of buccal mucosa and of esophagus: a randomized double-blind intervention study in China.

F. X. Bosch, N. Muñoz, M. Hayashi, 1987, Journal of the National Cancer Institute.

General Introduction—The Background to Human Papillomavirus and Cancer Research

F. X. Bosch, D. Jenkins, F. Bosch, 2020 .

Differential presence of Papillomavirus variants in cervical cancer: an analysis for HPV33, HPV45 and HPV58.

F. X. Bosch, S. de Sanjosé, L. Alemany, 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.

F. X. Bosch, N. Muñoz, K. Shah, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Evidence that wild-type p53 in neuroblastoma cells is in a conformation refractory to integration into the transcriptional complex

F. X. Bosch, G. Brandner, A. Wolff, 2001, Oncogene.

Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.

S. Franceschi, F. X. Bosch, N. Muñoz, 2011, The Lancet. Oncology.

Descriptive Epidemiology and Human Cancer

M. Coleman, F. X. Bosch, F. Bosch, 1994 .

Expression of cell cycle proteins in head and neck cancer correlates with tumor site rather than tobacco use.

K. Hörmann, F. X. Bosch, S. Haas, 2002, Oral oncology.

The path to eliminate cervical cancer in the world and the challenges of professional education.

F. Bosch, 2013, Vaccine.

HPV and cervical cancer: screening or vaccination?

F. X. Bosch, S. de Sanjosé, X. Castellsagué, 2008, British Journal of Cancer.

The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort

I. Gram, F. Clavel-Chapelon, A. Fournier, 2016, PloS one.

Human papillomavirus-related serological markers of invasive cervical carcinoma in Brazil.

F. X. Bosch, N. Muñoz, J. Walboomers, 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

The role of HPV in the etiology of cervical cancer.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1994, Mutation research.

[Advances in cervical cancer prevention: HPV vaccines].

X. Castellsagué, F. Bosch, 2007, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Epidemiology of cervical cancer.

F. X. Bosch, N. Muñoz, F. Bosch, 1989, IARC scientific publications.

Human papillomavirus and cervical cancer

F. X. Bosch, N. Muñoz, O. M. Jensen, 1989 .

Erratum: The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: Results from the EPIC cohort (PLoS ONE (2016) 11:1 (e0147029) DOI:10.1371/journal.pone.0147029)

F. Clavel-Chapelon, A. Fournier, E. Riboli, 2016 .

Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study.

M. Plummer, I. Gram, F. Clavel-Chapelon, 2011, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

BMI throughout life, intake of vitamin supplements and oral cancer in Spain.

S. Franceschi, F. X. Bosch, N. Muñoz, 2002, IARC scientific publications.

Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.

F. X. Bosch, N. Muñoz, X. Castellsagué, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Policy forum: public health. Reducing liver cancer--global control of aflatoxin.

F. X. Bosch, T. Troxell, S. Henry, 1999, Science.

Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: Evidence from the EPIC cohort

I. Gram, F. Clavel-Chapelon, E. Riboli, 2014, International journal of cancer.

Worldwide Genomic Diversity of the High-Risk Human Papillomavirus Types 31, 35, 52, and 58, Four Close Relatives of Human Papillomavirus Type 16

F. X. Bosch, N. Muñoz, G. Sánchez, 2005, Journal of Virology.

Prostitution, HIV, and cervical neoplasia: a survey in Spain and Colombia.

Second international workshop on the epidemiology of cervical cancer and human papillomavirus

F. X. Bosch, N. Muñoz, K. Shah, 1992 .

Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece

F. X. Bosch, S. Sanjosé, B. Lloveras, 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Broad-spectrum human papillomavirus vaccines: new horizons but one step at a time.

F. Bosch, 2009, Journal of the National Cancer Institute.

Human Papillomavirus Vaccination for the Prevention of Cervical and Other Related Cancers

F. X. Bosch, F. Bosch, 2013 .

Aflatoxin, hepatitis and worldwide liver cancer risks.

F. X. Bosch, S. Henry, F Xavier Bosch, 2002, Advances in experimental medicine and biology.

Importance of human papillomavirus endemicity in the incidence of cervical cancer: an extension of the hypothesis on sexual behavior.

G. Omenn, S. Franceschi, J. Kaldor, 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

CHAPTER 2 The epidemiology of human papillomavirus infection and its association with cervical cancer

X. Castellsagué, F. Bosch, Y. Qiao, 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)

M. Poljak, J. Cuzick, M. Jit, 2020, British Journal of Cancer.

Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1994, The Journal of infectious diseases.

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region☆

J. Cuzick, C. Wheeler, F. X. Bosch, 2016, Papillomavirus research.

The prospects of HPV vaccination in cervical cancer prevention: results of a new independent trial.

S. de Sanjosé, X. Castellsagué, F. Bosch, 2011, Cancer discovery.

HPV vaccines: public health and clinical guidelines

F. X. Bosch, F. Bosch, 2011 .

Intratype variation in 12 human papillomavirus types: a worldwide perspective

C. Wheeler, A. C. Stewart, J. Peto, 1996, Journal of virology.